Abstract:Naurah Nabihah Nasir, 1 Mahendran Sekar, 2, 3 Subban Ravi, 4 Ling Shing Wong, 5 Sreenivas Patro Sisinthy, 6 Siew Hua Gan, 2 Vetriselvan Subramaniyan, 7 Kumarappan Chidambaram, 8 Nur Najihah Izzati Mat Rani, 6 M Yasmin Begum, 9 Mohankumar Ramar, 10 Sher Zaman Safi, 11 Siddharthan Selvaraj, 12 Senthil Kumar Chinna Maruthu, 13 Shivkanya Fuloria, 14 Neeraj Kumar Fuloria, 14 Pei Teng Lum, 1 Sinouvassane Djearamane 15 1 Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh, Perak, 30450, Malaysia; 2 School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, 47500, Malaysia; 3 Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Institute of Medical and Technical Sciences, Saveetha Dental College and Hospital, Saveetha University, Chennai, Tamil Nadu, 600077, India; 4 Department of Chemistry, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, 641021, India; 5 Faculty of Health and Life Sciences, INTI International University, Nilai, 71800, Malaysia; 6 Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh, Perak, 30450, Malaysia; 7 Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Subang Jaya, Selangor, Malaysia; 8 Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, 62529, Saudi Arabia; 9 Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha, 61421, Saudi Arabia; 10 Department of Surgical Research, Rhode Island Hospital, Alpert Medical School, Brown University, Providence, RI, 02903, USA; 11 Faculty of Medicine, Bioscience and Nursing, MAHSA University, Jenjarom, Selangor, 42610, Malaysia; 12 Faculty of Dentistry, AIMST University, Bedong, Kedah, 08100, Malaysia; 13 Department of Pharmacology, Karpagam College of Pharmacy, Coimbatore, Tamilnadu, 641032, India; 14 Faculty of Pharmacy, AIMST University, Bedong, Kedah, 08100, Malaysia; 15 Department of Biomedical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar, Perak, 31900, Malaysia Correspondence: Ling Shing Wong, Faculty of Health and Life Sciences, INTI International University, Nilai, 71800, Malaysia, Tel +6014 – 3034057, Email Sinouvassane Djearamane, Department of Biomedical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar, 31900, Perak, Malaysia, Tel +6016 – 4037685, Email Streptonigrin is an aminoquinone alkaloid isolated from Streptomyces flocculus and is gaining attention as a drug molecule owing to its potential antitumor and antibiotic effects. It was previously used as an anticancer drug but has been discontinued because of its toxic effects. However, according to the most recent studies, the toxicity of streptonigrin and its structurally modified derivatives has been reduced while maintaining their potential pharmacological action at lower concentrations. To date, many investigations have been conducted on this molecule and its derivatives to determine the most effective molecule with low toxicity to enable new drug discovery. Therefore, the main objective of this study is to provide a comprehensive review and to discuss the prospects for streptonigrin and its derived compounds, which may boost the molecule as a highly interesting target molecule for new drug design, development and therapy. To complete this review, relevant literature was collected from several scientific databases, including Google Scholar, PubMed, Scopus and ScienceDirect. Following a complete screening, the obtained information is summarized in the present review to provide a good reference and accelerate the development and utilization of streptonigrin and its derivatives as pharmaceuticals. Graphical Keywords: streptonigrin, chemistry, biosynthesis, pharmacology, anticancer, antibacterial Graphical Streptonigrin is a metabolite of the bacterium Streptomyces flocculus which was first isolated in 1959 by Rao and Cullen using a combination of spectral and degradation methods. 1 Since the initial determination of its structure, streptonigrin has been the subject of extensive synthetic, biosynthetic and biological investigations, which have resulted in continued interest in its confirmed potential biological properties (Figure 1). Subsequently, the structure of the isolated metabolite was further investigated by Rao, Biemann and Woodward in 1963, 1</sup -Abstract Truncated-

A Novel Streptonigrin Type Alkaloid from the Streptomyces Flocculus CGMCC 4.1223 Mutant ΔstnA/Q2

Characterization of streptonigrin biosynthesis reveals a cryptic carboxyl methylation and an unusual oxidative cleavage of a N-C bond.

A New Β-Carboline Alkaloid from the Streptomyces Flocculus CGMCC4.1223 Mutant ΔstnK4

Discovery and Efficient Synthesis of a Biologically Active Alkaloid Inspired by Thiostrepton Biosynthesis

Insights into Quinaldic Acid Moiety Formation in Thiostrepton Biosynthesis Facilitating Fluorinated Thiopeptide Generation.

A Bifunctional Methyltransferase in Biosynthesis of Antitumor Antibiotic Streptonigrin

StnK2 Catalysing a Pictet-Spengler Reaction Involved in the Biosynthesis of the Antitumor Reagent Streptonigrin

Identification of (2 S ,3 S )-β-Methyltryptophan as the Real Biosynthetic Intermediate of Antitumor Agent Streptonigrin

Identification Of (2s,3s)-Beta-Methyltryptophan As The Real Biosynthetic Intermediate Of Antitumor Agent Streptonigrin

Crystal Structure of StnA for the Biosynthesis of Antitumor Drug Streptonigrin Reveals a Unique Substrate Binding Mode

Streptomyces nigra sp. nov. Is a Novel Actinobacterium Isolated From Mangrove Soil and Exerts a Potent Antitumor Activity in Vitro .

Streptonaphthyridine A, a New Naphthyridine Analogue with Antiproliferative Activity Against Human Glioma Cells from Mariana Trench-Associated Actinomycete Streptomyces Sp. SY2111

Cytotoxic and Antifungal Staurosporine Derivatives from Marine-Derived Actinomycete Streptomyces Sp. ZS-A121

Chemistry, Biosynthesis and Pharmacology of Streptonigrin: An Old Molecule with Future Prospects for New Drug Design, Development and Therapy

Flavoprotein StnP2 Catalyzes the Β-Carboline Formation During the Streptonigrin Biosynthesis

Biosynthesis of the Carbamoylated D‐Gulosamine Moiety of Streptothricins: Involvement of a Guanidino‐N‐glycosyltransferase and an N‐Acetyl‐D‐gulosamine Deacetylase

Xantholipin B produced by the stnR inactivation mutant Streptomyces flocculus CGMCC 4.1223 WJN-1

New Secondary Metabolites Produced by an Engineered Strain Streptomyces Sp. XZQH13OEΔastC.

A New Tetrahydrobenzofuranone Metabolite from Streptomyces Sp. HS-NF-853

A new staurosporine analog from Actinomycetes Streptomyces sp. (172614).

Identification of stsC, the gene encoding the L-glutamine:scyllo-inosose aminotransferase from streptomycin-producing Streptomycetes